Radius Recycling - RDUS Total Company Value-to-Revenue Ratio

radiuspharm.com (RDUS) - corporate logo

Radius Recycling, Inc. (RDUS) is developing metabolic pharmaceuticals through Tymlos distribution partnerships. This EV/Sales valuation chart demonstrates market expectations, where reflects the latest metric value. Radius Recycling, Inc. (RDUS) is implementing cyclical technologies to process metals into pure raw materials, while operational activities are strictly limited by FDA regulations regarding biomaterial disposal.

RDUS Radius Recycling, Inc.: Enterprise Value-to-Revenue Ratio in the range 07/04/2022 - 11/20/2026

Radius Recycling Inc. - analytical breakdowns and key metrics (RDUS)

Fundamental company valuation:Radius Recycling, Inc., RDUS
Product sample of Radius Recycling

This indicator determines the total enterprise value relative to annual revenue, excluding the impact of debt obligations to provide an objective assessment of the market value of assets. By analyzing the EV/Sales multiple, an investor can compare the fundamental value of Radius Recycling, Inc. (RDUS) with the steady demand for its specialized drugs, which allows for the determination of the company's fair price within a protected pharmaceutical market.

Competitor analysis for Radius Recycling, Inc.

ASND: Enterprise Value-to-Revenue Ratio|MDGL: EV/Sales Multiple|CORT - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Rhythm Corp|Akero Corp (AKRO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio metsera.com (MTSR)|Company Value to Revenue moonlaketx.com MLTX|EV/Sales Multiple CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Company Value to Revenue Ratio|SLNO - Enterprise Value-to-Revenue Ratio|Amicus Pharma (FOLD) - Company Value to Revenue|ETNB: EV/Sales Multiple|AGIO - Total Company Value-to-Revenue Ratio|Company Value to Revenue GPCR|Enterprise Value-to-Revenue Multiple MiMedx MDXG|Enterprise Value-to-Revenue Ratio Rezolute Corp (RZLT)|Company Value to Revenue Lexicon Corp LXRX|Enterprise Value-to-Revenue Ratio MBX Biosciences, Inc. MBX|EV/Sales Multiple altimmune.com ALT|AARD - Enterprise Value-to-Revenue Ratio|Sagimet - Enterprise Value-to-Revenue Coefficient|BioAge Labs Inc. (BIOA) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - EV/Sales Multiple|GUTS: Business Value to Revenue|Enterprise Value-to-Revenue Ratio vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Pluristem Therapeutics PLUR|SYBX: Company Value to Revenue Ratio|lipocine.com - EV/Sales Multiple|Enterprise Value to Sales Volume MTNB|SPRB: EV/Sales Multiple|Enterprise Value-to-Sales Ratio Galecto Inc GLTO|Enterprise Value-to-Revenue Ratio Carmell Corp|Lumos Therapeutics (LUMO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Organovo (ONVO)